Kezar Life Sciences, Inc. (KZR)

7.38 +0.04 (+0.54%) USD  |  NASDAQ  |  May 06, 16:00
7.38 0.00 (0.00%) After-Hours: 16:43
More

Kezar Life Sciences Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for KZR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Apellis Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade